文献速递冠心病外科

冠状动脉旁路移植术中完全与不完全血运重建的临床结局:TiCAB 试验分析

Clinical outcomes of complete versus incomplete revascularization in patients treated with coronary artery bypass grafting: insights from the TiCAB trial.
PubMed 文献 · Eur J Cardiothorac Surg · 2020-11-14

该研究为 TiCAB 试验的事后分析,纳入 1859 例接受冠状动脉旁路移植术(CABG)的患者,其中 1550 例(83.4%)接受完全血运重建(CR),309 例(16.6%)接受不完全血运重建(ICR)。结果显示 ICR 组术后 12 个月内再次血运重建风险显著升高(HR 1.91,95%CI 1.16-3.16),但两组全因死亡率无差异。

要点

  • ICR 组术后 12 个月内再次血运重建风险显著高于 CR 组(HR 1.91)。
  • ICR 组更常见慢性完全闭塞病变且更多采用非体外循环 CABG。
  • 两组全因死亡率无显著差异。

核心结论

  • ICR 患者入院时更稳定但移植血管更少,可能与慢性完全闭塞病变比例更高及采用 OPCAB 有关。
  • 尽管两组死亡率无差异,CR 在预防再次血运重建方面可能使患者获益。

研究设计与样本

  • TiCAB 试验的事后分析,共纳入 1859 例接受 CABG 的患者。
  • 其中 1550 例(83.4%)接受完全血运重建,309 例(16.6%)接受不完全血运重建。
  • 评估 CABG 术后 12 个月内的全因死亡、心血管死亡、心肌梗死、再次血运重建、卒中和出血结局。

主要发现

  • ICR 组术后 12 个月内再次血运重建风险显著增加(HR 1.91,95%CI 1.16-3.16;P < 0.01)。
  • ICR 组术后 12 个月内经皮冠状动脉介入治疗风险显著增加(HR 1.95,95%CI 1.13-3.35;P < 0.05)。
  • ICR 组再次血运重建风险升高独立于替格瑞洛或阿司匹林随机分配,且基线失衡校正后仍存在。
  • 基线特征:稳定型心绞痛 CR 68.9% vs ICR 71.2%,不稳定型心绞痛 14.1% vs 7.8%,非 ST 段抬高型心肌梗死 17.0% vs 21.0%(P < 0.01)。
  • 病变特征:慢性完全闭塞病变 CR 91.3% vs ICR 96.8%(P < 0.01);OPCAB 使用率 CR 3.0% vs ICR 6.1%(P < 0.01);移植血管总数 2.69/例 vs 2.49/例(P < 0.001)。

临床怎么用

  • 对于 CABG 患者,应尽可能实现完全血运重建以降低再次血运重建风险。
  • ICR 患者术后需加强监测,警惕再次血运重建需求。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: In this post hoc analysis of the Ticagrelor in coronary artery bypass grafting (CABG) trial, we aimed to analyse patients treated with CABG receiving either complete revascularization (CR) or incomplete revascularization (ICR) independent from random allocation to either ticagrelor or aspirin. METHODS: Of 1859 patients enrolled in the Ticagrelor in CABG trial, 1550 patients (83.4%) received CR and 309 patients (16.6%) ICR. Outcomes were evaluated regarding all-cause mortality, cardiovascular death, myocardial infarction (MI), repeat revascularization, stroke and bleeding within 12 months after CABG. RESULTS: Baseline parameters revealed significant differences regarding clinical presentation (stable angina pectoris: CR 68.9% vs ICR 71.2%, instable angina pectoris: 14.1% vs 7.8%, non-ST elevation MI: 17.0% vs 21.0%, P ˂ 0.01), lesion characteristics (chronic total occlusion: CR 91.3% vs ICR 96.8%, P ˂ 0.01), operative technique [off-pump coronary artery bypass surgery (OPCAB): CR 3.0% vs ICR 6.1%, P ˂ 0.01] and number of utilized grafts (total number of grafts: 2.69/patient vs 2.49/patient, P ˂ 0.001). ICR patients displayed a significantly increased risk of repeat revascularization [hazard ratio (HR) 1.91, 95% confidence interval (CI) 1.16-3.16; P < 0.01] and percutaneous coronary intervention (HR 1.95, 95% CI 1.13-3.35; P < 0.05) within 12 months after CABG. Higher risk for repeat revascularization in ICR patients was independent from random allocation to either ticagrelor or aspirin and persisted after adjustment for baseline imbalances. CONCLUSIONS: Patients with ICR presented more stable at the time of admission, but received less grafts, highly likely due to a higher rate of chronic total occlusion lesions and performed OPCAB. Although mortality presented no difference between groups, our results suggest that patients benefit from CR with regard to prevention of repeat revascularization.

来源:Eur J Cardiothorac Surg,查看原文。版权归原作者所有。

引用

  1. Schaefer A, Conradi L, Schneeberger Y, et al. Clinical outcomes of complete versus incomplete revascularization in patients treated with coronary artery bypass grafting: insights from the TiCAB trial. Eur J Cardiothorac Surg. 2020. PMID: 33188598. doi:10.1093/ejcts/ezaa330

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。